Mayer Geert, Frohnhofen Helmut, Jokisch Martha, Hermann Dirk M, Gronewold Janine
Department of Neurology, Philipps-Universität Marburg, Marburg, Germany.
Department of Orthopedics and Trauma Surgery, University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany.
Front Neurosci. 2024 Mar 22;18:1372326. doi: 10.3389/fnins.2024.1372326. eCollection 2024.
Due to worldwide demographic change, the number of older persons in the population is increasing. Aging is accompanied by changes of sleep structure, deposition of beta-amyloid (Aß) and tau proteins and vascular changes and can turn into mild cognitive impairment (MCI) as well as dementia. Sleep disorders are discussed both as a risk factor for and as a consequence of MCI/dementia. Cross-sectional and longitudinal population-based as well as case-control studies revealed sleep disorders, especially sleep-disorderded breathing (SDB) and excessive or insufficient sleep durations, as risk factors for all-cause MCI/dementia. Regarding different dementia types, SDB was especially associated with vascular dementia while insomnia/insufficient sleep was related to an increased risk of Alzheimer's disease (AD). Scarce and still inconsistent evidence suggests that therapy of sleep disorders, especially continuous positive airway pressure (CPAP) in SDB, can improve cognition in patients with sleep disorders with and without comorbid dementia and delay onset of MCI/dementia in patients with sleep disorders without previous cognitive impairment. Regarding potential pathomechanisms via which sleep disorders lead to MCI/dementia, disturbed sleep, chronic sleep deficit and SDB can impair glymphatic clearance of beta-amyloid (Aß) and tau which lead to amyloid deposition and tau aggregation resulting in changes of brain structures responsible for cognition. Orexins are discussed to modulate sleep and Aß pathology. Their diurnal fluctuation is suppressed by sleep fragmentation and the expression suppressed at the point of hippocampal atrophy, contributing to the progression of dementia. Additionally, sleep disorders can lead to an increased vascular risk profile and vascular changes such as inflammation, endothelial dysfunction and atherosclerosis which can foster neurodegenerative pathology. There is ample evidence indicating that changes of sleep structure in aging persons can lead to dementia and also evidence that therapy of sleep disorder can improve cognition. Therefore, sleep disorders should be identified and treated early.
由于全球人口结构变化,老年人口数量正在增加。衰老伴随着睡眠结构的改变、β-淀粉样蛋白(Aβ)和tau蛋白的沉积以及血管变化,并可能发展为轻度认知障碍(MCI)和痴呆症。睡眠障碍既被视为MCI/痴呆症的危险因素,也被视为其后果。基于人群的横断面和纵向研究以及病例对照研究表明,睡眠障碍,尤其是睡眠呼吸紊乱(SDB)和睡眠时间过长或过短,是全因MCI/痴呆症的危险因素。关于不同类型的痴呆症,SDB尤其与血管性痴呆相关,而失眠/睡眠不足与阿尔茨海默病(AD)风险增加有关。稀少且仍不一致的证据表明,睡眠障碍的治疗,尤其是SDB中的持续气道正压通气(CPAP),可以改善有或无合并痴呆症的睡眠障碍患者的认知,并延缓无先前认知障碍的睡眠障碍患者MCI/痴呆症的发病。关于睡眠障碍导致MCI/痴呆症的潜在病理机制,睡眠障碍、慢性睡眠不足和SDB会损害β-淀粉样蛋白(Aβ)和tau的类淋巴清除,导致淀粉样蛋白沉积和tau聚集,从而导致负责认知的脑结构发生变化。食欲素被认为可调节睡眠和Aβ病理。它们的昼夜波动会因睡眠碎片化而受到抑制,其表达在海马萎缩时受到抑制,这有助于痴呆症的进展。此外,睡眠障碍会导致血管风险增加和血管变化,如炎症、内皮功能障碍和动脉粥样硬化,从而促进神经退行性病变。有充分证据表明,老年人睡眠结构的改变会导致痴呆症,也有证据表明睡眠障碍的治疗可以改善认知。因此,应尽早识别和治疗睡眠障碍。